We provided extensive feedback on the National Institute for Health and Care Excellence (NICE) Chronic Pain Assessment and Management Guideline proposed in the United Kingdom, responded to calls for public comment from the Drug Enforcement Agency and the Oregon Health Authority, and offered solicited testimony during state opioid hearings in Minnesota.
